Commentary on H. Ide et al., "Tyk2 expression and its signaling enhances the invasiveness of prostate cancer cells".
Schuster
Christian
C
Department of Pharmacology, Medical University of Vienna, Waehringerstrasse 13A, A-1090 Vienna, Austria.
Müller
Mathias
M
Freissmuth
Michael
M
Sexl
Veronika
V
Stoiber
Dagmar
D
D000818:Animals; D002051:Burkitt Lymphoma / Q000201:enzymology; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D008297:Male; D051379:Mice; D009361:Neoplasm Invasiveness; D011471:Prostatic Neoplasms / Q000201:enzymology* / Q000473:pathology*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects; D053634:TYK2 Kinase / Q000037:antagonists & inhibitors / Q000378:metabolism*
D047428:Protein Kinase Inhibitors; D053634:TYK2 Kinase